Showing results (211-220 of 323) with videos related to

Sort By:
Pageof 33
Cancer Research and Treatment|May 19, 2016
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant GliomaYongjun Cha, Yu Jung Kim, Se-Hoon Lee, et al.
Plos One|October 23, 2018
A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database studyIn Sil Choi, Jee Hyun Kim, Ju Hyun Lee, et al.
Thrombosis Research|March 25, 2022
Treatment patterns of thrombopoietin receptor agonists among adults with primary immune thrombocytopenia: A Korean nationwide population-based studyJi Yun Lee, Ju-Hyun Lee, Sang-A Kim, et al.
Breast Cancer Research and Treatment|March 19, 2017
Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practiceYu Jin Lim, Sea-Won Lee, Noorie Choi, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2013
HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancerJi-Won Kim, Jee Hyun Kim, Seock-Ah Im, et al.
Palliative & Supportive Care|December 22, 2017
Is spirituality related to survival in advanced cancer inpatients in Korea?Dong Wook Shin, Sang-Yeon Suh, Sun-Hyun Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|January 13, 2026
Durvalumab-containing treatment for recurrent or metastatic pulmonary sarcomatoid carcinoma: A pooled post hoc analysis of two KCSG phase II trialsDong Hyun Kim, Miso Kim, Jeonghwan Youk, et al.
Cancer Investigation|February 9, 2008
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancerYu Jung Kim, Min A Kim, Seock-Ah Im, et al.
Lung Cancer (Amsterdam, Netherlands)|November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyHyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.
Thoracic Cancer|November 9, 2022
The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non-small cell lung cancer treated with immune checkpoint inhibitorsJieun Yang, Se Hyun Kim, Eun Hee Jung, et al.
Pageof 33